Evidence map›Paper›PMID 35668743›Full record

ArticleCancer management and research2022

Epidemiological and Histopathological Characteristics of Renal Cell Carcinoma in Somalia.

Abdikarim Hussein Mohamed, Ismail Mohamud Abdullahi, Aşır Eraslan, Hussein Ali Mohamud, Metin Gur

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution.

Abdikarim Hussein MohamedUrology Department, Mogadishu Somalia Turkish Training and Research Hospital, Mogadishu, Somalia.ORCID 0000-0002-3892-6269
Ismail Mohamud AbdullahiPathology Department, Mogadishu Somalia Turkish Training and Research Hospital, Mogadishu, Somalia.ORCID 0000-0001-9276-4558
Aşır EraslanUrology Department, Mogadishu Somalia Turkish Training and Research Hospital, Mogadishu, Somalia.
Hussein Ali MohamudUrology Department, Mogadishu Somalia Turkish Training and Research Hospital, Mogadishu, Somalia.
Metin GurUrology Department, Mogadishu Somalia Turkish Training and Research Hospital, Mogadishu, Somalia.
Mogadishu Somali Turkish Training and Research Hospital

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is a scarcity of studies regarding renal cell carcinoma (RCC) reported from Sub-Saharan Africa. Objective: The present study is the first report evaluating the prevalence and clinical and histopathological features of RCC at a tertiary hospital in Somalia. Methods: This retrospective study included 84 patients with histologically confirmed RCC over 5-years. The investigated parameters were sociodemographic features, radiological and histopathological characteristics, mortality, and overall 5-year survival rate. Results: The prevalence of RCC in our study was 0.7%. The mean age of the patients was 53.74±5.5 years, 67.9% were male, and 32.1% were female, with a 2:1 male-to-female ratio. The mean tumor size was 6.38±2.4 cm. Clear cell RCC was the most common histological type in 67.8%, followed by papillary RCC (15.6%), unclassified RCC (9.5%), and chromophobe RCC was the least common in 7.1% of the cases. About one-third of the case had locally advanced RCC with positive nodal involvement, 26.2% of the patients had metastatic disease, and a further 6% progressed to metastatic cancer despite surgical resection. Eight percent of our cases returned with local recurrence. The mortality rate was 37.2%. More than eighty percent of females had a low-stage and a low-grade RCC, while males held higher stages and higher grades RCC in 37% and 63%, respectively (p<0.001). Smokers were male-only, while obesity was common in female patients (p=0.02). Conclusion: The study findings showed a satisfactory outcome, 71.4% of our patients presented with localized RCC, the five-year survival rate of the patients was 62.8%, and the mortality rate was substantially higher for patients with a higher stage, a higher grade tumor, and metastatic disease at the time of diagnosis.

Indexed as

five-year survival ratemortalityrenal cell carcinomaSub-Saharan Africa

Identifiers

PMID35668743
PMCPMC9166404
OpenAlexW4281822440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.